The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
This review provides a foundation to prepare you to assess, identify treatment (including pharmacotherapy), and prevent further complications in patients with sickle cell disease. Mild-to-moderate complications, such as acute pain crisis which are treated in an acute care unit and more severe complications related to emboli that often require transfer to intensive care, are reviewed.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/3/23.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online nursing continuing professional development (NCPD) evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures: There are no disclosures to declare.
Speakers Conflict of Interest Disclosure: There are no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or corporate sponsorship was received.
Accreditation Statement: This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
Learning Outcome: After completing this learning activity, the participant will have increased knowledge of the history and systemic racism that continues to impact those living with sickle cell disease and the appropriate pharmacotherapy for a crisis.